Premier Debt to Equity Ratio 2012-2024 | PINC
Current and historical debt to equity ratio values for Premier (PINC) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Premier debt/equity for the three months ending September 30, 2024 was 0.00.
| Premier Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-09-30 | $1.36B | $1.95B | 0.70 |
| 2024-06-30 | $1.44B | $1.96B | 0.73 |
| 2024-03-31 | $1.44B | $1.92B | 0.75 |
| 2023-12-31 | $1.44B | $2.39B | 0.60 |
| 2023-09-30 | $1.50B | $2.35B | 0.64 |
| 2023-06-30 | $1.04B | $2.33B | 0.44 |
| 2023-03-31 | $1.18B | $2.34B | 0.50 |
| 2022-12-31 | $1.23B | $2.31B | 0.54 |
| 2022-09-30 | $1.16B | $2.26B | 0.51 |
| 2022-06-30 | $1.11B | $2.25B | 0.49 |
| 2022-03-31 | $1.28B | $2.23B | 0.57 |
| 2021-12-31 | $1.17B | $2.28B | 0.52 |
| 2021-09-30 | $1.24B | $2.33B | 0.53 |
| 2021-06-30 | $1.29B | $2.23B | 0.58 |
| 2021-03-31 | $1.47B | $2.22B | 0.66 |
| 2020-12-31 | $1.34B | $2.17B | 0.62 |
| 2020-09-30 | $1.31B | $2.14B | 0.61 |
| 2020-06-30 | $1.09B | $1.86B | 0.59 |
| 2020-03-31 | $1.26B | $1.80B | 0.70 |
| 2019-12-31 | $0.95B | $1.67B | 0.57 |
| 2019-09-30 | $0.90B | $1.69B | 0.54 |
| 2019-06-30 | $0.91B | $1.66B | 0.55 |
| 2019-03-31 | $1.05B | $1.64B | 0.64 |
| 2018-12-31 | $0.94B | $1.70B | 0.55 |
| 2018-09-30 | $0.83B | $1.68B | 0.50 |
| 2018-06-30 | $0.82B | $1.49B | 0.55 |
| 2018-03-31 | $0.90B | $1.40B | 0.64 |
| 2017-12-31 | $0.87B | $1.45B | 0.60 |
| 2017-09-30 | $0.99B | $1.51B | 0.66 |
| 2017-06-30 | $1.03B | $1.48B | 0.70 |
| 2017-03-31 | $4.01B | $-1.41B | -2.85 |
| 2016-12-31 | $3.96B | $-1.35B | -2.94 |
| 2016-09-30 | $0.67B | $1.22B | 0.55 |
| 2016-06-30 | $0.67B | $1.19B | 0.57 |
| 2016-03-31 | $0.71B | $1.15B | 0.61 |
| 2015-12-31 | $0.71B | $1.08B | 0.66 |
| 2015-09-30 | $0.69B | $1.01B | 0.68 |
| 2015-06-30 | $0.57B | $0.96B | 0.59 |
| 2015-03-31 | $0.55B | $0.94B | 0.59 |
| 2014-12-31 | $0.54B | $0.89B | 0.61 |
| 2014-09-30 | $0.46B | $0.82B | 0.56 |
| 2014-06-30 | $0.47B | $0.77B | 0.61 |
| 2014-03-31 | $0.48B | $0.72B | 0.66 |
| 2013-12-31 | $0.46B | $0.63B | 0.73 |
| 2013-09-30 | $0.24B | $0.28B | 0.84 |
| 2013-06-30 | $0.21B | $0.39B | 0.55 |
| 2013-03-31 | $0.00B | $0.00B | 0.00 |
| 2012-12-31 | $0.00B | $0.00B | 0.00 |
| 2012-09-30 | $0.00B | $0.00B | 0.00 |
| 2012-06-30 | $0.20B | $0.36B | 0.55 |
| 2011-06-30 | $0.00B | $0.00B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.067B | $1.346B |
| Premier, Inc. operates as a healthcare alliance. The company brings together hospitals, health systems, physicians and other healthcare providers primarily in the United States. It also maintains clinical, financial and outcomes databases. Premier, Inc. is headquartered in Charlotte, North Carolina. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $84.995B | 10.55 |
| Cencora (COR) | United States | $43.734B | 16.44 |
| DiDi Global (DIDIY) | China | $22.941B | 0.00 |
| Natera (NTRA) | United States | $20.871B | 0.00 |
| ICON (ICLR) | Ireland | $16.879B | 15.03 |
| Viatris (VTRS) | United States | $14.478B | 4.46 |
| Avantor (AVTR) | United States | $14.307B | 21.45 |
| Revvity (RVTY) | United States | $13.453B | 23.37 |
| BioMerieux (BMXMF) | France | $12.659B | 0.00 |
| CochLear (CHEOY) | Australia | $11.807B | 0.00 |
| Solventum (SOLV) | United States | $11.540B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.417B | 29.35 |
| Doximity (DOCS) | United States | $10.302B | 60.64 |
| Charles River Laboratories (CRL) | United States | $9.314B | 18.00 |
| HealthEquity (HQY) | United States | $8.212B | 41.20 |
| Sonic Healthcare (SKHHY) | Australia | $8.208B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.322B | 29.43 |
| Amplifon S.p.A (AMFPF) | Italy | $5.864B | 29.89 |
| Sotera Health (SHC) | United States | $3.759B | 20.11 |
| Organon (OGN) | United States | $3.719B | 3.75 |
| BrightSpring Health Services (BTSG) | United States | $2.967B | 63.11 |
| Surgery Partners (SGRY) | United States | $2.493B | 28.42 |
| Concentras Parent (CON) | United States | $2.491B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.291B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.069B | 0.00 |
| PACS (PACS) | United States | $1.992B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.969B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.730B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.711B | 44.90 |
| Teladoc Health (TDOC) | United States | $1.544B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.224B | 11.98 |
| Progyny (PGNY) | United States | $1.208B | 24.47 |
| Embecta (EMBC) | United States | $1.161B | 8.12 |
| CareDx (CDNA) | United States | $1.102B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.090B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.874B | 5.91 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| Agilon Health (AGL) | United States | $0.775B | 0.00 |
| SBC Medicals (SBC) | United States | $0.649B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.492B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.478B | 0.00 |
| DocGo (DCGO) | United States | $0.444B | 16.73 |
| Sonida Senior Living (SNDA) | United States | $0.441B | 0.00 |
| Enhabit (EHAB) | United States | $0.387B | 33.48 |
| Sera Prognostics (SERA) | United States | $0.275B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.268B | 0.00 |
| LifeMD (LFMD) | United States | $0.212B | 0.00 |
| Biodesix (BDSX) | United States | $0.198B | 0.00 |
| Beauty Health (SKIN) | United States | $0.176B | 0.00 |
| Nutex Health (NUTX) | United States | $0.160B | 0.00 |
| ModivCare (MODV) | United States | $0.156B | 8.44 |
| MultiPlan (MPLN) | United States | $0.108B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.099B | 0.00 |
| So-Young (SY) | China | $0.093B | 15.69 |
| IceCure Medical (ICCM) | Israel | $0.052B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.050B | 0.00 |
| OncoCyte (OCX) | United States | $0.037B | 0.00 |
| NeueHealth (NEUE) | United States | $0.033B | 0.87 |
| Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.023B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.023B | 0.00 |
| Oncology Institute (TOI) | United States | $0.016B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| KindlyMD (KDLY) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |
| Aclarion (ACON) | United States | $0.001B | 0.00 |